evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting

After an extensive evaluation process where Sapio demonstrated an understanding of evitria’s complex workflow needs, the company chose Sapio ELN and Sapio Report Builder to streamline complex workflows, and Sapio Report Generator will enable the creation of customized reports directly from the system

Written bySapio Sciences
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.

Zurich-based evitria has established itself as a premier CHO-based transient expression services provider for antibodies and other recombinant proteins, serving a diverse clientele ranging from academic laboratories to global biopharmaceutical companies.

After an extensive evaluation process where Sapio demonstrated an understanding of evitria’s complex workflow needs, the company chose Sapio ELN and Sapio Report Builder to streamline complex workflows, and Sapio Report Generator will enable the creation of customized reports directly from the system.

<b ><span lang="EN-US">Stefan Schmidt, CEO of evitria</span></b>

Stefan Schmidt, CEO of evitria, commented: “Working with Sapio Sciences marks a significant step forward in our workflow and data management capabilities. The highly flexible Sapio solution nicely captures our existing workflows, streamlining data capture and processing, requiring only limited retooling of our processes or retraining for our employees. It also provides a platform for future growth and optimization, and we are confident that this integration will enhance our ability to serve our global client base with even greater efficiency and precision.”




<b ><span lang="EN-US">Mike McCartney, Chief Commercial Officer at Sapio</span></b>

Mike McCartney, Chief Commercial Officer at Sapio, commented: “We are thrilled to partner with evitria, a true innovator in antibody expression services. The Sapio platform was designed to meet the evolving needs of life sciences organizations like evitria, reinforcing our mission to elevate science and empower scientists. Our team’s deep understanding of scientific workflows allowed us to address evitria’s specific needs and showcase our commitment to accelerating discovery and improving lives.”





Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio&nbsp;
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems